Progress in Medical Physics (PMP) encompasses all aspects of research related to the physics in medicine and biology. The content of manuscript should not be published previously nor submitted concurrently for the publication elsewhere.

All authors have to read and agreed to its content and that the manuscript conforms to the journal’s policies Ethics in publishing. Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.

Manuscripts in English should be submitted to the Editorial Committee by through the on-line submission system accessible at the homepage (http://www.progmedphys.org/submission/Login.html). A separate letter previously published paper should be submitted. Electronic manuscripts should be prepared using the Microsoft Word. Authors may submit their manuscript and track their progress to final decision. Reviewers can download manuscripts and submit their report to the editor. All manuscripts are peer reviewed.

All manuscripts are sent to the referees selected by the Editorial Committee for the peer review and acceptance, rejection, or recommendations for revision is decided. This journal operates a single blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final.

Submissions can be in the form of (1) Original articles, (2) Review articles, (3) Technical notes, and (4) Letters to the editor.

• (1) Original articles (Word limit 8,000 words)
  Original articles should describe the aspects of translational research within the scope of the journal. Papers should have original contents or in-depth analysis and should not have been already published. Critical and new results of experiments or theories should be described in full-length research papers.
• (2) Review articles (Word limit 14,000 words)
  These articles should be critical, in-depth literature-based reviews that include the author's perspective. The reviews should not merely be catalogs of the literature; instead they should provide the expert’s perspective. Reviews must include a statement of literature search that explains the search methodology used along with the author's criteria for including/excluding articles. Review articles must include a narrative abstractive that summarizes the key elements of the review.
• (3) Technical notes (Word limit 4,000 words)
  Technical notes should be in the form of a brief communication highlighting the details of a medical physics or biology, which effectively address a clinical issue or problem. Articles in this category introduce scientific work on novel skills dealing with new methods and techniques.
• (4) Letters to the editor (Word limit 2,000 words)
  Any issues of interests to the journal readership may be contained in letters to the editor. Letters concerning articles published earlier will generally be sent to the author of the previous research for possible response before publication.

• (1) Title page
  Title page should be submitted separately with main manuscript. Title page must contain the following information:
  • • Title
    Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
  • • Author names and affiliations
    Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled with positions and ORCIDs. You can add your name between parentheses in your own script behind the English transliteration. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lowercase superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
  • • Corresponding author
    Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. This responsibility includes answering any future queries about Methodology and Materials. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.
  • • Present/permanent address
    If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
• (2) Main manuscript
  • • Abstract and Keywords
    The Abstract should be structured in sub-sections (Purpose, Methods, Results, and Conclusions). A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. Non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. At the end of the abstract, keywords (not more than five) must be included to be used for indexing and bibliography searching. The Abstract should be no longer than 300 words.
    For the selection of keywords, refer Medical Subject Heading in Index Medicus or in internet site, http://www.nlm.nih.gov/mesh/MBrowser.html.
  • • Introduction
    State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results. Take particular care in describing the motivations for the study and its interest for the current research in the field.
  • • Materials and Methods
    Sufficient details should be provided to allow the work to be reproduced by an independent researcher. Already published methods should be summarized, and indicated by a reference. Any modifications to existing methods should be described. The section related to statistical analysis should have information on applied statistical tests and programs.
  • • Results
    Results should be clear and concise. They should contain a description of the findings of the study, without a repetition of the ways in which those findings have been obtained (which should appear in the Material and Methods section) and without authors' own comments on those findings (which should appear in the Discussion section).
  • • Discussion
    This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is not considered appropriate, unless for Technical Notes. Avoid extensive citations and discussion of published literature.
  • • Conclusions
    The main conclusions of the study should be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion section.
  • • References
    References should be cited with Arabic numerals in brackets, numbered in the order cited, e.g. [1, 3-5]. References in the list should be the following format with names and initials of all authors when six or fewer, otherwise only the first three adding “et al.”.
    • - Book
      1. Khan FM. The physics of radiation therapy. 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2009:11-31.
    • - Book chapter
      2. Chen GTY, Pelizzari CA: Imaging in radiotherapy. Treatment Planning in Radiation Oncology. Baltimore: Williams & Wilkins; 1998:11-31.
    • - Journal article
      3. Park JM, Kim JI, Choi CH, Chie EK, Kim IH, Ye SJ. Photon energy-modulated radiotherapy: Monte Carlo simulation and treatment planning study. Med Phys. 2012;39:1265–77.
    • - In press
      4. Meckley T, Reed Y, Greenfield R. Giant cell formation in rabbit long-term bone marrow cultures. J Bone Miner Res 2003. doi: 10.1359/JBMR.0303011.
    • - Website
      5. Hooper JF. Psychiatry & the Law: Forensic Psychiatric Resource Page. Tuscaloosa (AL): University of Alabama, Department of Psychiatry and Neurology, 1999 [cited 2007 Feb 23]. Available from: http://bama.ua.edu/~jhooper/.
    • - Report
      6. ICRU Report 35. Radiation dosimetry: electron beams with energies between 1 and 50 MeV. ICRU Report. Bethesda: ICRU. 1984;35.
    • - Proceedings
      7. Sohnle PG, Hahn BL, Fassel TA, Kushnaryov VM. Analysis of fluconazole’s effects on Candida albicans viability during extended incubations. Paper presented at: 13th Congress of the International Society for Human and Animal Mycology; 1997 Jun 8-13; Parma, Italy.
    • - Thesis
      8. Kim KS. Pathology review [dissertation]. Seoul: Korea University; 2012.
  • • Figures and Tables
    Each figure as an individual file that is separate from the manuscript in submission system. The figure label and figure title is required for figure captions. When naming your figures, match the figure file name and the caption label with the corresponding in-text citations in the manuscript. Example: a figure file named “Fig1.tif” should match the citation “Fig 1” and the figure label “Fig 1.” in the caption.
  • • Author Contributions
    The contributions of all authors must be described. PMP has adopted the CRediT Taxonomy to describe each author’s individual contributions to the work. Author should use the CRediT taxonomy to describe each contribution. Please see the full list of roles at CRediT website (https://casrai.org/credit/).
    The submitting author is responsible for providing the contributions of all authors at submission. The description for Author Contributions should be separately submitted with main manuscript.
    All authors should be have reviewed, discussed, and agreed to their individual contributions ahead of this time. Contributions will be published with the final article, and they should accurately reflect contributions to the work. PMP will contact all authors by email at submission to ensure that they are aware of the submission.
    • - Example of author contributions:
      Conceptualization: ***, ***. Data curation: ***, ***. Formal analysis: ***, ***. Funding acquisition: ***, ***. Investigation: ***, ***. Methodology: ***, ***. Project administration: ***, ***. Resources: ***, ***. Software: ***, ***. Supervision: ***, ***. Validation: ***, ***. Visualization: ***, ***. Writing – original draft: ***, ***. Writing – review & editing: ***, ***.
  • • Acknowledgements
    Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
  • • Formatting of Funding Sources
    List funding sources in this standard way to facilitate compliance to funder's requirements:
    Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].
    It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding.
    If no funding has been provided for the research, please include the following sentence:
    This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors.

• (1) Copyright
  The authors grant the Progress in Medical Physics to own the full copyright of the final version of this article once it is accepted for publication.
  The authors hereby warrant that this article is an original work, has not been previously published elsewhere either in printed or electronic form and is not under consideration for publication elsewhere.
  The authors hereby warrant that this article contains no violation of any existing copyright.
  The authors will indemnify the Editors and the Progress in Medical Physics against all claims and expenses arising from any breach of this warranty on the authors’ behalf in this Agreement.
  The authors hereby warrant that they have obtained permission from the copyright owner to reproduce in this article (in all media including print and electronic form) material not owned by the authors, and that they have acknowledged the source.
  The authors attest that they have herein disclosed any and all financial and other relationships that could be construed as conflicts of interest, and that all sources of financial support for this study are disclosed in the manuscript.
  The authors warrant that research involving human subjects and animals was approved by the applicable institutional ethics committee or review board and that all experiments were conducted in conformity with ethical and humane principles of research.
• (2) Registration of the Clinical Research and Data Sharing Policy Any research that deals with clinical trial should be registered to the primary national clinical trial registration site such as http://cris.nih.go.kr/cris/index.jsp, or other sites accredited by World Health Organization or ICMJE (http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html).
  This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors”. The ICMJE's policy regarding trial registration is explained at http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trialregistration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.-and-editorial-issues/clinical-trialregistration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.
• (3) Charges
  PMP levies an article-processing charge of KRW 300,000 for each article accepted for publication, including VAT. We can waive charges for non-Korean authors under approval of editorial board. Authors can request a waiver or discount during the submission process.
• (4) Communications to the publisher
  We invite inquiries to the editorial management team at any time during the editorial process. For all matters concerning presubmission, editorial policies, procedures, business inquiries, subscription information, orders, or changes of address, please contact editorial office.
• (5) Publishing period
  Publishing Date The journal is published quarterly at the end of March, June, September, and December.